Manufacturers Trader Service OEM

Calbiotech, Inc.

1935 Cordell Ct. , 92020 San Diego, CA
USA

Telephone +1 619 660-6162
Fax +1 619 660-6970
dbarka@calbiotech.com

This company is co-exhibitor of
Messe Düsseldorf North America

Trade fair hall

  • Hall 3 / C30-14
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 3): stand C30-14

Fairground map

MEDICA 2016 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.02  Anemia related / Vitamin tests

Anemia related / Vitamin tests

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.02  Anemia related / Vitamin tests
  • 03.02.02.01  Diagnostic agents / kits for vitamin determination

Diagnostic agents / kits for vitamin determination

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.02  Anemia related / Vitamin tests
  • 03.02.02.03  Reagents for vitamin determination

Reagents for vitamin determination

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.03  Auto-immune diseases

Auto-immune diseases

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.03  Auto-immune diseases
  • 03.02.03.01  Diagnostics / kits for the diabetes analyses

Diagnostics / kits for the diabetes analyses

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.03  Auto-immune diseases
  • 03.02.03.02  Diagnostics / kits for the gastro enterology

Diagnostics / kits for the gastro enterology

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.03  Auto-immune diseases
  • 03.02.03.03  Diagnostics / kits for the thyroid gland analyses (Auto-immune diseases)

Diagnostics / kits for the thyroid gland analyses (Auto-immune diseases)

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.04  Fertility / Pregnancy hormones / Proteins

Fertility / Pregnancy hormones / Proteins

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.05  Units and systems for hormone determination

Units and systems for hormone determination

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.05  Units and systems for hormone determination
  • 03.02.05.01  Diagnostic agents / kits for hormone determination

Diagnostic agents / kits for hormone determination

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.06  Thyroid function hormones

Thyroid function hormones

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.06  Thyroid function hormones
  • 03.02.06.01  Diagnostic agents / kits for thyroid gland, etc. determination (Thyroid function hormones)

Diagnostic agents / kits for thyroid gland, etc. determination (Thyroid function hormones)

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.06  Thyroid function hormones
  • 03.02.06.04  Reagents for thyroid gland diagnostics

Reagents for thyroid gland diagnostics

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems

Immuno assay systems

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  • 03.02.07.06  Enzyme immunoassay (EIA, ELISA, EMIT)

Enzyme immunoassay (EIA, ELISA, EMIT)

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  • 03.02.07.15  Luminescence immunoassay (LIA, SPALT)

Luminescence immunoassay (LIA, SPALT)

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  • 03.02.07.16  Luminescence-enhanced immunoenzymatic assay (LIEMA)

Luminescence-enhanced immunoenzymatic assay (LIEMA)

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.09  Individual and specified hormones

Individual and specified hormones

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.09  Individual and specified hormones
  • 03.02.09.01  Diagnostic agents / kits for determination of growth hormones

Diagnostic agents / kits for determination of growth hormones

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.09  Individual and specified hormones
  • 03.02.09.02  Diagnostic agents / kits for determination of Leptin

Diagnostic agents / kits for determination of Leptin

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.14  Specific proteins

Specific proteins

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.14  Specific proteins
  • 03.02.14.01  C-reactive proteins (CRP)

C-reactive proteins (CRP)

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.15  Rapid tests - Immunochemistry

Rapid tests - Immunochemistry

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.15  Rapid tests - Immunochemistry
  • 03.02.15.01  Pregnancy tests

Pregnancy tests

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.15  Rapid tests - Immunochemistry
  • 03.02.15.02  Infectious disease tests

Infectious disease tests

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.16  Therapeutic drug monitoring

Therapeutic drug monitoring

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.16  Therapeutic drug monitoring
  • 03.02.16.01  Diagnostic agents / kits for determination of therapeutic drugs

Diagnostic agents / kits for determination of therapeutic drugs

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.17  Tumor markers
  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.17  Tumor markers
  • 03.02.17.01  Diagnostic agents / kits for tumour marker determination

Diagnostic agents / kits for tumour marker determination

Our products

Product category: Tumor markers

AFP ELISA

Catalog number: AF064T
Product type: ELISA
Quantity: 96 Tests (12x8 breakable strip wells)
Standard range: 5-500 ng/ml
Analytical Sensitivity: 5 ng/ml
Sample volume: 25 µl/well
Species: Human
Storage and Stability: Product should be stored at 2-8 °C.
Precautions: For research use only. Not for use in diagnostic procedures.

References: 1. Bates SE. Clinical applications of serum tumor markers. Ann Intern Med 1991;115:623-8.
2. Wu JC, Lee SD, Hsaio KJ, et al. Mass screening of primary hepatocellular carcinoma by alpha-fetoprotein in a rural area of Taiwan-a dried blood spot method. Liver 1988;8:100-4.
3. Lee H-S, Chung YH, Kim CY. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma. Hepatology 1991;14:68-72.
4. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Intern Med 1988;108:390-401.
5. Sato Y, Nakata K, Kato Y, et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993;328:1802-6.
6. Deutch HF. Chemistry and biology of alpha- fetoprotein. Adv Cancer Res 1991;56:253-312.

More Less

Product category: Tumor markers

CA-125 ELISA

Catalog number: CA239T
Product type: ELISA
Quantity: 96 Tests (12x8 breakable strip wells)
Standard range: 15-400 U/mL
Sample volume: 50 µl/well
Species: Human
Storage and Stability: Product should be stored at 2-8 °C.

Precautions: Potential biohazardous materials:
The calibrator and controls contain human source components, which have been tested and found non-reactive for hepatitis B surface antigen as well as HIV antibody with FDA licensed reagents. However, as there is no test method that can offer complete assurance that HIV, Hepatitis B virus or other infectious agents are absent, these reagents should be handled at the Biosafety Level 2, as recommended in the Centers for Disease Control/National Institutes of Health manual, "Biosafety in Microbiological and Biomedical Laboratories." 1984
This test kit is designed for Research Use Only.
Do not pipette by mouth. Do not smoke, eat, or drink in the areas in which specimens or kit reagents are handled.
The components in this kit are intended for use as an integral unit. The components of different lots should not be mixed.
It is recommended that serum samples be run in duplicate.
Optimal results will be obtained by strict adherence to this protocol. Accurate and precise pipetting, as well as following the exact time and temperature requirements prescribed are essential. Any deviation from this may yield invalid data.

References: all, E., Methods in Enzymology, Volume 70, Van Vunakis, H. and Langone, J. J. (eds.), Academic Press, New York, 419- 492 (1980).
tila, M., Ruoslahti, E. and Engvall, E., J. lmmunol. Methods, 42, 11-15 (1981).
Kenemans P, Yedema CA, Bon GG, von Mensdorff-Pouilly S. Ca125 in gynecological pathology a review. Eur J Obstet Gynecol 1993;49:115-124.
Saksela F. Prognostic markers in epithelial ovarian cancer. Intl J Gynecol Pathol 1993;12:156-161.
Farghaly SA. Tumor markers in gynecologic cancer. Gynecol & Obstet Invest 1992;34:65-72.
Welander CE. What do CA 125 and other antigens tell us about ovarian cancer biology. Acta Obstet Gynecol Scand Sup 1992;155:85-93.
McGowan L. Pathology of the ovary. Curr Opin on Obstet Gynecol 1991;3:580-586.
Niloff JM. Ovarian malignancy. Curr Opin on Obstet Gynecol 1991;3:66-72.
Olt G, Berchuck A, Bast RC. The role of tumor markers in gynecologic oncology. Obstet Gynecol Survey 1990;45-:570-577.
Diez M, Cerdan FJ, Ortega MD, Torres A, Picardo A, Balibrea JL. Evaluation of serum CA125 as a tumor marker in non-small cell lung cancer. Cancer 1991;67:150-154.
Niloff JM, Klug TL, Schaetzl E. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. AM J. Obstet Gynecol 1984; 148:1057

More Less

Product category: Tumor markers

Neuron Specific Enolase (NSE) ELISA

Catalog number: NS193T
Product type: ELISA
Quantity: 96 Tests (12x8 breakable strip wells)
Standard range: 5-150 ng/ml
Analytical Sensitivity: 5 ng/ml
Sample volume: 25 µl/well
Species: Human
Application: The Calbiotech NSE ELISA is intended for the quantitative measurement of NSE in human serum or plasma.

Principle: The Calbiotech NSE ELISA kit is a solid phase direct sandwich ELISA. The standards, samples and controls are added into the selected wells which are pre-coated with anti human NSE monoclonal anybody along with an anti-NSE-HRP conjugated pair match antibody. NSE, in the standards, controls and patient samples binds to anti-NSE antibody in the wells and anti-NSE-HRP conjugated antibody binds to the NSE. The unbound glycolytic enzyme enolase, NSE, is washed off by wash buffer. Upon the addition of the TMB substrate, the intensity of color developed is proportional to the concentration of NSE in the samples. A standard curve is prepared relating color intensity to the concentration of the NSE.

Storage and Stability: Product should be stored at 2-8 °C. Product is stable for 24 months from the date of manufacturing.
Precautions: For research use only. Not for use in diagnostic procedures.

References: 1. F.J. Tapia;A.J.A. Barbosa; P.J. Marangos; J.M. Polak; S.R. Bloom; C. Dermody; A.G.E. Pearse. Neuron-Specific Enolase is produced by neuroendocrine tumours. The Lancet 1981; 317: 808-811

2. E. Paus; K. Nustad: Immunoradiometric Assay for αγ- and γγ-Enolase (Neuron-Specific Enolase), with Use of Monoclonal Antibodies and Magnetizable Polymer Particles. Clin. Chem.1989, 35: 2034-2038.

3. K. Iwase, A. Kato, et al. Enolase subunits in patients with neuroendocrine tumors. J Clin Endocrinol Metab 1986; 63:94-101.

4. D. Schmechel, PJ Marangos, AP Zis, M. Brightman, FK. Goodwin. The brain enolase specific markers of neuronal and glia cells. Science 1978; 199:313-5

5. P. Ellisabeth, N. Kjell. Immunoradiometric assay for the αγ and γγ –enolase (Neurons-Spacific Enolase), with use of monoclonal antibodies and magnetizable polymer particles. Clin. Chem. 1989, 35/10, 2034-2038

More Less

Product category: Tumor markers

Neuron Specific Enolase (NSE) ELISA for CSF

Catalog number: NS215T
Product type: ELISA
Quantity: 96 Tests (12x8 breakable strip wells)
Standard range: 2-105 ng/ml
Analytical Sensitivity: 2 ng/ml
Sample volume: 25 µl/well
Species: Human
Application: The Calbiotech NSE ELISA is intended for the quantitative measurement of NSE in human CSF.

Principle: The Calbiotech NSE ELISA kit is a solid phase direct sandwich ELISA. The standards, samples and controls are added into the selected wells which are pre-coated with anti human NSE monoclonal anybody along with an anti-NSE-HRP conjugated pair match antibody. NSE, in the standards, controls and patient samples binds to anti-NSE antibody in the wells and anti-NSE-HRP conjugated antibody binds to the NSE. The unbound glycolytic enzyme enolase, NSE, is washed off by wash buffer. Upon the addition of the TMB substrate, the intensity of color developed is proportional to the concentration of NSE in the samples. A standard curve is prepared relating color intensity to the concentration of the NSE.
Storage and Stability Product should be stored at 2-8 °C. Product is stable for 24 months from the date of manufacturing.
Precautions For research use only. Not for use in diagnostic procedures.

References: 1. F.J. Tapia;A.J.A. Bar
bosa; P.J. Marangos; J.M. Polak; S.R. Bloom; C. Dermody; A.G.E. Pearse. Neuron-Specific Enolase is produced by neuroendocrine tumours. The Lancet 1981; 317: 808-811

2. E. Paus; K. Nustad: Immunoradiometric Assay for αγ- and γγ-Enolase (Neuron-Specific Enolase), with Use of Monoclonal Antibodies and Magnetizable Polymer Particles. Clin. Chem.1989, 35: 2034-2038.

3. K. Iwase, A. Kato, et al. Enolase subunits in patients with neuroendocrine tumors. J Clin Endocrinol Metab 1986; 63:94-101.

4. D. Schmechel, PJ Marangos, AP Zis, M. Brightman, FK. Goodwin. The brain enolase specific markers of neuronal and glia cells. Science 1978; 199:313-5

5. P. Ellisabeth, N. Kjell. Immunoradiometric assay for the αγ and γγ –enolase (Neurons-Spacific Enolase), with use of monoclonal antibodies and magnetizable polymer particles. Clin. Chem. 1989, 35/10, 2034-2038

More Less

Product category: Diagnostic agents / kits for tumour marker determination

CA 19-9 ELISA

Catalog number: CA238T
Product type: ELISA
Quantity: 96 Tests (12x8 breakable strip wells)
Standard range: 25-600 U/mL
Sample volume: 25 µl/well
Species: Human
Storage and Stability: Store the kit at 2 - 8°
Keep microwells sealed in a dry bag with desiccants.
The reagents are stable until expiration of the kit.
Do not expose reagents to heat, sun, or strong light.

Precautions: This test kit is designed for Research Use Only.
The calibrator and controls contain human source components, which have been tested and found non-reactive for hepatitis B surface antigen as well as HIV antibody with FDA licensed reagents. However, as there is no test method that can offer complete assurance that HIV, Hepatitis B virus or other infectious agents are absent, these reagents should be handled at the Biosafety Level 2, as recommended in the Centers for Disease Control/National Institutes of Health manual, "Biosafety in Microbiological and Biomedical Laboratories." 1984
Do not pipette by mouth. Do not smoke, eat, or drink in the areas in which specimens or kit reagents are handled.
The components in this kit are intended for use as an integral unit. The components of different lots should not be mixed.
It is recommended that standards and serum samples be run in duplicate.
Optimal results will be obtained by strict adherence to this protocol. Accurate and precise pipetting, as well as following the exact time and temperature requirements prescribed are essential. Any deviation from this may yield invalid data.

References: Glenn, J., Steinberg, W.M., Kurtzman, S.H., et at. Evaluation of the utility of a radioimmunoassay for serum CA 19-9 level in patients before and after treatment of carcinoma of the pancreas. J. Clin. Oncol. 1988; 6:462-8.

Hayakawa, T., Kondo, T., Shibata, T. et al. Sensitive serum markers for detecting pancreatic cancer. Cancer 1988; 61:1827-31.

Koprowski, H., Herly, M., Steplewski, Z., et al. Specific antigen in serum of patients with colon carcinoma. Science 1981; 212:53-5

Malesci, A., Tommasini, M.A., Bonato, C. et al. Determination of CA19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. Gastroenteroglogy 1987; 92:60-

Safi, F, Roscher, R., Bittner, R., et al. High sensitivity and specificity of CA 19-9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings. Pancreas 1987; 2:398-403.

Steinberg, W. The clinical utility of CA 19-9 tumor associated antigen. American J. of Gastroenterology 1990; 85:350-355.

Steinberg, W.M., Gelfand, R., Anderson, K.K., et al. Comparison of the sensitivity and specificity of the CA 19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986; 90:343-9.

Takasaki, H., Uchida, E., Tempero, M.A., et al. Correlative study on expression of CA 19-9 and DU-Pan-2 in tumor tissue and in serum of pancreatic cancer patients. Cancer Res. 1988; 48:1435-8.

Tatsuta, M., Yamamura, H., Iishi H., et al. Values of CA19-9 in the serum, pure pancreatic juice and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor. Cancer 1985; 56:2669-73.

Wang, T.H. Lin, J.W., Chen, D.S., et al. Noninvasive diagnosis of advanced panceatic cancer by real-time ultrasonography, carcinoembryonic antigen, and carbohydrate antigen 19-9. Pancreas 1986; 1:219-23.

Strom BL, Maislin G, West SL, et al. Serum CEA and CA19-9: potential future diagnostic or screening tests for gallbladder cancer? Int. J. Cancer 1990; 45:8

More Less

About us

Company details

Calbiotech custom develops and manufactures immunoassay products used by major reference labs, universities and research centers around the world, including ELISA, Ultra-Sensitive Chemiluminescent ELISA, RIA and PCR kits for IVD, RUO & ASR applications. Calbiotech operates under cGMP and ISO 13485 Standards in an FDA Registered Facility in San Diego, California. Calbiotech also offers unique blood, saliva and research animal kits for clinical and pre-clinical testing. Calbiotech’s CLIA certified laboratory focuses on servicing Clinical Trials and customized testing.

More Less

Company data

Sales volume

10-49 Mio US $

Export content

max. 50%

Number of employees

20-49

Foundation

1998

Area of business

Diagnostics